BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10072870)

  • 1. [Mutation and expression of p53 gene in nasopharyngeal carcinoma, cervical carcinoma and lung cancer].
    Xie Y; Yao K; Hu W
    Zhonghua Bing Li Xue Za Zhi; 1997 Aug; 26(4):229-32. PubMed ID: 10072870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of the p53 protein accumulation and p53 gene mutation in squamous cell carcinoma of the lung].
    Li S; Liu H; Wang D
    Zhonghua Bing Li Xue Za Zhi; 1998 Apr; 27(2):123-6. PubMed ID: 11244963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The expression of tumor suppressor gene p53 and Rb gene in nasopharyngeal carcinoma].
    Song Y; Wang L; Huang G; Huang R; Yuan S; Liu Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1997 Sep; 28(3):268-71. PubMed ID: 10684031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A hot-spot mutation of p53 gene in nasopharyngeal carcinoma].
    Chen R; Zhu D; Yin W
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):401-4. PubMed ID: 8697986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between p53 gene mutation and protein expression in 30 cases of human lung cancer].
    Zhang J; Zheng J; Fang W
    Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):846-9. PubMed ID: 11038779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The expression of nm23-H1 and p53 protein in nasopharyngeal carcinoma].
    Zhou Y; Xu A; Ling X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 Jun; 12(6):243-6. PubMed ID: 11189166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutation in human nasopharyngeal carcinomas.
    Lo KW; Mok CH; Huang DP; Liu YX; Choi PH; Lee JC; Tsao SW
    Anticancer Res; 1992; 12(6B):1957-63. PubMed ID: 1295443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
    Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
    Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
    Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E
    Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rearrangement of p53 gene with overexpressed p53 protein in primary cervical cancer.
    Sahu GR; Nayak BK; Patnaik S; Parija T; Das BR
    Oncol Rep; 2002; 9(2):433-7. PubMed ID: 11836622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma.
    Sun Y; Hegamyer G; Cheng YJ; Hildesheim A; Chen JY; Chen IH; Cao Y; Yao KT; Colburn NH
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6516-20. PubMed ID: 1631151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers.
    Chang YL; Wu CT; Lin SC; Hsiao CF; Jou YS; Lee YC
    Clin Cancer Res; 2007 Jan; 13(1):52-8. PubMed ID: 17200338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bcl-2, p53 expression and Epstein-Barr virus infection in primary nasopharyngeal carcinoma].
    Cheng Q; Liu G; Wu Z; Wu Y; Xiao B
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 15(10):455-7. PubMed ID: 12541691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas.
    Niedobitek G; Agathanggelou A; Barber P; Smallman LA; Jones EL; Young LS
    J Pathol; 1993 Aug; 170(4):457-61. PubMed ID: 8410495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 overexpression in nasopharyngeal carcinoma.
    Agaoglu FY; Dizdar Y; Dogan O; Alatli C; Ayan I; Savci N; Tas S; Dalay N; Altun M
    In Vivo; 2004; 18(5):555-60. PubMed ID: 15523893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress of RASSF1A gene in neoplasms].
    Xing XS; Huang LM; Ma XD
    Zhonghua Bing Li Xue Za Zhi; 2004 Dec; 33(6):562-4. PubMed ID: 15634458
    [No Abstract]   [Full Text] [Related]  

  • 18. Overexpression of oxidored-nitro domain containing protein 1 inhibits human nasopharyngeal carcinoma and cervical cancer cell proliferation and induces apoptosis: Involvement of mitochondrial apoptotic pathways.
    Ouyang J; Wu M; Huang C; Cao L; Li G
    Oncol Rep; 2013 Jan; 29(1):79-86. PubMed ID: 23124592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection.
    Lo KW; Mok CH; Chung G; Huang DP; Wong F; Chan M; Lee JC; Tsao SW
    Anticancer Res; 1992; 12(6B):1989-94. PubMed ID: 1363512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of p53 mutation using PCR-SSCP silver staining method].
    Zhao W; Si J; Li K; Zhang X; Song G
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Jun; 17(3):219-22. PubMed ID: 8706159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.